Distribution and genetic diversity of Dothistroma septosporum in Pinus brutia forests of south-western Turkey

The support of the DIAROD project, funded as EU COST Action FP1102, is gratefully acknowledged. Forest engineers Ali Datumani and Erdal Örtel are thanked for their great help in the field. We are grateful to the anonymous reviewers who helped improve the manuscript. We would like to thank Dr Alkan Unlu for providing the climate data and to Dr Ilker Ercanli for performing the statistical analysis. The study was financially supported by the Forestry Commission, United Kingdom and by the European Regional Development Fund, Project Phytophthora Research Centre Reg. No. CZ.02.1.01/0.0/0.0/15_003/0000453.Peer reviewedPostprin

Bandwidth Estimation for Admission Control in MANET: Review and Conceptual MANET Admission Control Framework

The widespread of wireless mobile network have increased the demand for its applications. Providing a reliable QoS in wireless medium, especially mobile ad-hoc network (MANET), is quite challenging and remains an ongoing research trend. One of the key issues of MANET is its inability to accurately predict the needed and available resources to avoid interference with already transmitting traffic flow. In this work, we propose a resource allocation and admission control (RAAC) solution. RAAC is an admission control scheme that estimates the available bandwidth needed within a network, using a robust and accurate resource estimation technique. Simulation results obtained show that our proposed scheme for MANET can efficiently estimate the available bandwidth and outperforms other existing approaches for admission control with bandwidth estimation

What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol

Stilbenes are naturally occurring phytoalexins that generally exist as their more stable E isomers. The most well known natural stilbene is resveratrol (Res), firstly isolated in 1939 from roots of Veratrum grandiflorum (white hellebore) (1) and since then found in various edible plants, notably in Vitis vinifera L. (Vitaceae) (2). The therapeutic potential of Res covers a wide range of diseases, and multiple beneficial effects on human health such as antioxidant, anti-inflammatory and anti-cancer activities have been suggested based on several in vitro and animal studies (3). In particular, Res has been reported to be an inhibitor of carcinogenesis at multiple stages via its ability to inhibit cyclooxygenase, and is an anticancer agent with a role in antiangiogenesis (4). Moreover, both in vitro and in vivo studies showed that Res induces cell cycle arrest and apoptosis in tumor cells (4). However, clinical studies in humans evidenced that Res is rapidly absorbed after oral intake, and that the low level observed in the blood stream is caused by a fast conversion into metabolites that are readily excreted from the body (5). Thus, considerable efforts have gone in the design and synthesis of Res analogues with enhanced metabolic stability. Considering that reduced Res (dihydro- resveratrol, D-Res) conjugates may account for as much as 50% of an oral Res dose (5), and that D-Res has a strong proliferative effect on hormone-sensitive cancer cell lines such as breast cancer cell line MCF7 (6), we recently devoted our synthetic efforts to the preparation of trans-restricted analogues of Res in which the E carbon-carbon double bond is embedded into an imidazole nucleus. To keep the trans geometry, the two aryl rings were linked to the heteroaromatic core in a 1,3 fashion. Based on this design, we successfully prepared a variety of 1,4-, 2,4- and 2,5-diaryl substituted imidazoles including Res analogues 1, 2 and 3, respectively, by procedures that involve transition metal-catalyzed Suzuki-Miyaura cross-coupling reactions and highly selective N-H or C-H direct arylation reactions as key synthetic steps. The anticancer activity of compounds 1–3 was evaluated against the 60 human cancer cell lines panel of the National Cancer Institute (NCI, USA). The obtained results, that will be showed and discussed along with the protocols developed for the preparation of imidazoles 1–3, confirmed that a structural optimization of Res may provide analogues with improved potency in inhibiting the growth of human cancer cell lines in vitro when compared to their natural lead. (1) Takaoka,M.J.Chem.Soc.Jpn.1939,60,1090-1100. (2) Langcake, P.; Pryce, R. J. Physiological. Plant Patology 1976, 9, 77-86. (3) Vang, O.; et al. PLoS ONE 2011, 6, e19881. doi:10.1371/journal.pone.0019881 (4) Kraft, T. E.; et al. Critical Reviews in Food Science and Nutrition 2009, 49, 782-799. (5) Walle, T. Ann. N.Y. Acad. Sci. 2011, 1215, 9-15. doi: 10.1111/j.1749-6632.2010.05842.x (6) Gakh,A.A.;etal.Bioorg.Med.Chem.Lett.2010,20,6149-6151

EPIdemiology of Surgery-Associated Acute Kidney Injury (EPIS-AKI) : Study protocol for a multicentre, observational trial

More than 300 million surgical procedures are performed each year. Acute kidney injury (AKI) is a common complication after major surgery and is associated with adverse short-term and long-term outcomes. However, there is a large variation in the incidence of reported AKI rates. The establishment of an accurate epidemiology of surgery-associated AKI is important for healthcare policy, quality initiatives, clinical trials, as well as for improving guidelines. The objective of the Epidemiology of Surgery-associated Acute Kidney Injury (EPIS-AKI) trial is to prospectively evaluate the epidemiology of AKI after major surgery using the latest Kidney Disease: Improving Global Outcomes (KDIGO) consensus definition of AKI. EPIS-AKI is an international prospective, observational, multicentre cohort study including 10 000 patients undergoing major surgery who are subsequently admitted to the ICU or a similar high dependency unit. The primary endpoint is the incidence of AKI within 72 hours after surgery according to the KDIGO criteria. Secondary endpoints include use of renal replacement therapy (RRT), mortality during ICU and hospital stay, length of ICU and hospital stay and major adverse kidney events (combined endpoint consisting of persistent renal dysfunction, RRT and mortality) at day 90. Further, we will evaluate preoperative and intraoperative risk factors affecting the incidence of postoperative AKI. In an add-on analysis, we will assess urinary biomarkers for early detection of AKI. EPIS-AKI has been approved by the leading Ethics Committee of the Medical Council North Rhine-Westphalia, of the Westphalian Wilhelms-University Münster and the corresponding Ethics Committee at each participating site. Results will be disseminated widely and published in peer-reviewed journals, presented at conferences and used to design further AKI-related trials. Trial registration number NCT04165369

Efficacy of different doses palliative radiotherapy on painful bone metastases [Agrili kemik metastazlarinda farkli dozlardaki palyatif radyoterapinin agri skoruna etkisi]

Aim: to compare the efficacy of 1x8 gy, 5x4 gy, 10x3 gy doses of palliative radiotherapy on painful bone metastases Method: In this study, 3 different dose fractionation irradiation schedules which consist of 1x800 cgy, 5x400 cgy, 10x300 cgy have been evaluated in 25 patients with 29 painful bone metastases, applied to radiation oncology department of çukurova university between february 2002-september 2004. Results: 25 patients with 29 painful bone metastases were included in the study. Follow-up duration was 30 days. The age range was 28-74 with a mean age of 52. Eleven patients were female and 14 were male. At the end of the study, , no statistically significant difference was detected for pain palliation proportions (p=0.677) between study groups. Conclusion: the results of the present study were concordant with the previous studies, which reported 70-80 % pain palliation. 1x800 cgy and 5x400 cgy therapy programs are preferable in patients with poor life expectancy, poor general condition, and immobile and suitable anatomical localization. © 2010 Düzce Medical Journal

Effect of several ionic liquids on the synthesis of 1,3-diphenyl-3- (phenylamino)propan-1-one in supercritical carbondioxide

We found that in a scCO2-ionic liquid hybrid reaction system, Mannich reaction of benzaldehyde, aniline and acetophenone can be remarkably accelerated and the yield of Mannich base 1,3-diphenyl-3-(phenylamino)propan-1- one was significantly high. This system would be available for the green reactions with good performance. © The Royal Society of Chemistry 2011